
56.86 Delayed Data As of Dec 11 | ![]() Today’s Change | 43.60 Today|||52-Week Range 58.01 | +23.42% Year-to-Date |
Is Sanofi's Stock a Buy? Dec 04 / MotleyFool.com - Paid Partner Content |
Previous close | 56.94 |
Today’s open | 56.61 |
Day’s range | 56.58 - 56.92 |
Volume | 931,807 |
Average volume (3 months) | 1,431,090 |
Market cap | $102.3B |
Earnings growth (last year) | +8.07% |
Earnings growth (this year) | -0.03% |
Earnings growth (next 5 years) | +9.77% |
Revenue growth (last year) | +4.51% |
P/E ratio | 23.5 |
Price/Sales | 6.31 |
Price/Book | 17.07 |
Today’s change | Today’s % change | |
---|---|---|
GSKGlaxoSmithKline | +0.14 | +0.30% |
LLYEli Lilly and Co | +0.13 | +0.11% |
SNYSanofi | +0.92 | +1.91% |
AZNAstraZeneca | +0.21 | +0.44% |
Next reporting date | February 5, 2020 |
EPS forecast (this quarter) | $0.57 |
Annual revenue (last year) | $17.7B |
Annual profit (last year) | $6.1B |
Net profit margin | 34.54% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bagsværd, Capital Region |